Relmada Therapeutics - 53 Year Dividend History | RLMD
Historical dividend payout and yield for Relmada Therapeutics (RLMD) since 1971. The current TTM dividend payout for Relmada Therapeutics (RLMD) as of November 20, 2024 is $0.00. The current dividend yield for Relmada Therapeutics as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.083B |
$0.000B |
|
Relmada Therapeutics Inc. is a clinical stage, public specialty pharmaceutical company. The Company is developing LevoCap ER, an abuse resistant, once-a-day sustained release dosage form of the opioid analgesic levorphanol; d-methadone, the NDMA receptor antagonist for neurophatic pain; BuTab ER, an oral dosage form of the opioid analgesic buprenorphine and MepiGel, a FDA Orphan Drug designated topical formulation of the local anesthetic mepivacaine. Relmada Therapeutics Inc. is based in New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
